Pancreatic Stone Protein (PSP) in Pregnant Women
Launched by NICOLE OCHSENBEIN · Sep 18, 2014
Trial Information
Current as of June 28, 2025
Unknown status
Keywords
ClinConnect Summary
Pregnant women feature a complex immunological condition caused by pregnancy itself and hence women present with an increased susceptibility to some infectious and non-infectious inflammatory diseases. Specifically regulated mechanisms have been described occurring in normal whereas lacking in pathological pregnancies in both the native and adaptive immune system in animal models and humans. However, clinically relevant biomarker associated with preterm premature rupture of membranes (PPROM), amniotic infection syndrome (AIS) as well as pregnancy associated complications such as preeclampsi...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 years
- • Healthy women with single pregnancy
- • Women with PPROM, AIS, preeclampsia, or HELLP syndrome
- • Patients able to provide informed consent
- Exclusion Criteria:
- • Viral (hepatitis B virus, hepatitis C virus, human immunodeficiency virus) or confirmed bacterial infections
About Nicole Ochsenbein
Nicole Ochsenbein is a dedicated clinical trial sponsor known for her commitment to advancing medical research and improving patient outcomes. With a strong background in clinical development and regulatory affairs, she leads initiatives that focus on innovative therapies and treatment modalities across various therapeutic areas. Nicole collaborates closely with researchers, healthcare professionals, and regulatory bodies to ensure the integrity and efficacy of clinical trials, fostering an environment of transparency and ethical practices. Her leadership is characterized by a patient-centered approach, emphasizing the importance of participant safety and informed consent throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, , Switzerland
Patients applied
Trial Officials
Nicole Ochsenbein, Prof. Dr.
Principal Investigator
University of Zurich
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials